BCG
Binah Capital Group, Inc. Common Stock
Mentions (24Hr)
0.00% Today
Reddit Posts
Mentions
Were you high when you just wrote that? The studies being an MIT study and BCG study. How does only 5-10% meaningful gain not equal almost no value for anyone? You think 95-90 is smaller than 5-10?
💎🙌 [IBRX] — The Next Big Short Squeeze Nobody’s Ready For 🚀 (My Deep Dive) Alright you beautiful degenerates, I think I just stumbled onto something filthy. Been digging deep into [Ticker IBRX], and what I’m seeing looks like the perfect setup for a short squeeze of biblical proportions. 🧠 Quick Thesis: Insanely high short interest north of 74% on a tiny 98M float, recent ANKTIVA FDA wins lighting a fire under retail while shorts choke on near-100% utilization. And with RFK Jr. now HHS boss draining the big pharma swamp, regulatory roadblocks are crumbling—time to stick it to the suits who’ve been burying actual cancer cures for decades. 💰 The Numbers (aka receipts): • Market Cap: $2.40B • Float: 98.33 million shares • Short Interest: 74.70% (still a beast, even after some covering 🔥) • Days to Cover: 8 • Insider Buying: Yes (117M+ shares scooped up in last 12 months, insiders own 66%+) • Catalyst: Q3 Earnings Nov 12 + sBLA submission for BCG-unresponsive NMIBC + CAR-NK data drop in H2, all supercharged by RFK Jr.’s FDA shakeup greenlighting real innovation over cartel BS 🧨 Why This Screams Short Squeeze: • Shorts are trapped — borrow rates at 1.59% but only 2.6M shares available (utilization ~97%, they’re sweating bullets) • Low float means every buy pushes this thing like a trampoline • Volume drying up = pressure cooker about to blow • Options chain looking spicy AF with call OI stacking heavy at $3 strikes (196K+ contracts total, apes piling in) 📈 Chart Ape Section: Looks like it’s coiling tighter than your ex’s budget. Price hugging above SMA20/50 with RSI at 54 ready to rip higher, and relative volume holding steady quiet before the retail storm hits. 🛡️ RFK Jr. & Regulatory Rage: RFK’s in the HHS hot seat, ally to ImmunityBio founder Soon-Shiong, and he’s got three pipeline apps queued at FDA that big pharma’s been cockblocking. This ain’t just stock plays, it’s apes vs. the machine denying cancer patients real shots at survival. Load up and flip the bird to the denialists; Anktiva’s already saving bladders, next up: lymphoma, glioblastoma, and beyond. Make Cancer Healthy Again 🚀 🧩 Bear Case (because I’m not totally braindead): • Market could nuke everything • Company might dilute (but hey, they just raised clean cash) • Or we could all just be early (and early = wrong in WSB time) 🚨 My Play: • Current Price: Current Price: $2.44 • My Position: 8375k shares • Target: $5 short-term / $10 long-term • Thesis: Shorts have overplayed their hand. All it takes is one spark like RFK fast-tracking that sBLA and this goes full $GME 2.0 mode, curing cancer and crushing hedgies in one glorious moonshot.
"Ai", or what it currently actually is LLMs, is just the latest step in corporate enshitification imo. According to BCG only 5% firms using ais are seeing meaningful returns, meaningful gains being revenue or productivity gains. The MIT study showed a very similar percentage, being 10%. All these companies have massively gambled on an immature technology that's still years, potentially decades, from reaching its promised potential. Meanwhile thousands of people have lost their jobs and energy prices are sky rocketing. China is getting double the value of of pushing Ai. The first being the obvious production of new technology and the later being western nations screwing themselves with unemployment and high energy cost. China has other fields for people to work while western nations, specifically the US, is very digitalized. "Ai" should be reserved for research and devlopment until it could produce actual value. The way it's looking now there's not going to be some massive pay off that justified the spending and cutting of jobs anytime soon.
Total quantum computing market (all delivery models): McKinsey’s latest puts 2035 revenues at $28–$72B for computing alone (and ~$97B for all quantum tech), growing further toward 2040. BCG’s framing is similar in timing and emphasizes security impacts by the mid-2030s.  AI derived stat (https://www.mckinsey.com/capabilities/mckinsey-digital/our-insights/the-year-of-quantum-from-concept-to-reality-in-2025)
BCG worth a look. Low float, been rising off the bottom the last little while with positive gains the last 5 days. $2.3 area now expecting $4-6 within the weeks or so
Some CEOs or board members job is to destroy the companies value from within. Often they are hired from outside by BCG (Boston Consulting Group) which has a record of "helping" out struggling companies and just hitting the final nail in the coffin. Ask ToysRus
There are better opportunities waiting cut rates. Low float stocks are better. Check what did CWD. I think next week BCG with only 2 mln float could spike very hard.
I mean, anyone who has studied the BCG matrixes, knows that Pepsi is a Cash Cow - a strong, established brand in a low-growth market that serves as a financial backbone for company’s portfolio.
They can't be worse than BCG can they?
So did BCG also consult on this too lol
Is BCG on the board or what? This company is in trouble.
On the right track there. The difference between a corp like PLTR and say Tableau & Qlik is the latter 2, you hire crap Accenture/BCG/Delot devs and end up with a unmaintainable broken system while PLTR does it all in-house and incorporated into a clunky product where it sort of works. At least login always works. They all allow you to see nice graphics (node graphs). And all the node graphs eventually point to one super node: a wendy's dumpster.
Hey should go after those crooks at BCG
Throwback to when two BCG executives modeled how much it would cost to relocate all the Palestinians out of Gaza and what the logistics cost and process flow would look like Then they are shocked they got demoted from Partner
BCG matrix comes to mind - but intel, oracle etc are all legends I respect!
Consulting is Big 3 (McKinsey, Bain, BCG) and accounting is Big 4 (KPMG, PwC, Deloitte, EY), completely different companies.
update BCG (boston consulting group) predicted 250 000 000 000 euros and more as necessary investments in outdated european power grid till 2029... gues what dlkv-r-a is doing all over europe 😁
Biggest waste of money any company can spend is with McKinsey, BCG or Bain.
Same crap with BCG. These talkers convince a room full of bigwigs to spend tens of millions on how to optimize the flow of traffic within a retail space, for example.
Still extremely hard. The big ones like BCG, McKinsey, Deloitte, PwC, Bain, EY-Parthenon, Accenture, are going to recruit actively from top 10 programs before even considering anyone else. The only real way around this is going to be knowing someone there already.
BCG is licking their wounds in a corner because you called them environment green.
Someone times consultants like BCG and McKinley are brought on to gut the company and make money on the way down. Look at Red Lobster, selling their property just to rent it back at a higher price was obviously meant to drag the company down till they can get that sweet bankruptcy jackpot at the end of the shit slide.
Yeah, fair take but I think people miss that companies don’t always hire McKinsey or BCG for new ideas. There are actual innovation consultants out there (like IDEO for example), but at the end of the day, most of the work at the big elite firms (McKinsey, Bain, BCG, etc) is about validating what the client already wants to do, packaged in a way that looks rigorously validated and totally defensible to their board and the general public. It’s a way to de-risk big decisions internally and externally bc if it fails, well hey, at least it was XYZ consulting firm that said it was a good idea, not us! So yeah, a lot of projects and 'advice' from these firms sounds dumb as shit like the HBO Max > Max > HBO Max again thing, but there's a reason these firms stay in business and recruit kids from top MBA programs for like $250k a year: it's a reputation machine and clients's aren't just paying for the advice - they're paying for who signed off on it. That’s the open secret
Lmao. Company I previously worked for payed many millions to BCG for consultation on business growth and how to improve market fit. They came back and said “👍 keep doing what your doing, looks good” Company folded a year later.
[“Let’s discuss the mechanisms of their evil methods, they find an Amazon competitor and then they wreck it. They hire BCG - the overpriced consultants, suddenly the company is defamed and insulted. Double agents on the board making terrible decisions, while their buddies short the stock and none of them have gone to prison. RadioShack - they hired BCG - so did Sears, Toys R Us, and all the dead companies. It seems that Boston Consulting Group is grim reaper for Amazon. Monopoly the game - you find the competition? Where they gone?”](https://youtu.be/_vAaRowRugo?si=0T2iORH-hccOdeww)
Ryan Cohen had some choice words about BCG early in the gamestonk saga. https://x.com/ryancohen/status/1507194761622470656?lang=en https://x.com/ryancohen/status/1507046110497492992?lang=en
Definitely not the case for the top consulting firms like McKinsey, BCG, etc. They are extremely competitive to even get a foot in the door.
Wait til you read about Boston Consulting Group (BCG)
Looks like they have a former BCG member on the board. I'd say it's cooked.
What are you talking about? https://pmc.ncbi.nlm.nih.gov/articles/PMC7280699/#:~:text=The%20Norwegian%20government%20managed%20to,of%20citizen%20trust%20in%20government "Until March 12, the government hesitated and took a wait‐and‐see approach to the epidemic, with the director of the NDH, in particular, seeking to reassure the public. But on that day, draconian regulations were implemented. Initially, these consisted of major restrictions on social contact and movement, which on March 24 were extended to April 13. They were followed by four rounds of economic compensation packages and then by a decision to pass a law granting exceptions, which represented a watering down by parliament of the government's initial proposal." "After three weeks of draconian measures, Norway became the first European country to claim that the situation was under control, as the number of hospitalized COVID‐19 patients decreased and the number of deaths remained low. This high‐performing Norwegian handling of the coronavirus pandemic must be understood in the context of competent politicians, a high‐trust society with a reliable and professional bureaucracy, a strong state, a good economic situation, a big welfare state, and low population density." And how about Japan? https://en.m.wikipedia.org/wiki/COVID-19_pandemic_in_Japan "On 27 February 2020, he requested the temporary closure of all Japanese elementary, junior high, and high schools until early April 2020.[14] On 7 April 2020, Abe proclaimed a one-month state of emergency for Tokyo and the prefectures of Kanagawa, Saitama, Chiba, Osaka, Hyogo, and Fukuoka.[15] On 16 April 2020, the declaration was extended to the rest of the country for an indefinite period.[16] The state of emergency was lifted in an increasing number of prefectures during May 2020, extending to the whole country by 25 May 2020.[17] On 7 January 2021, Suga declared a state of emergency for Tokyo and the prefectures of Chiba, Saitama and Kanagawa, effective from 8 January until 7 February.[18] Japan's death rate per capita from coronavirus is one of the lowest in the developed world, despite its aging population. Factors speculated to explain this include the government response, a milder strain of the virus, cultural habits such as bowing etiquette and wearing face masks, handwashing with sanitizing equipment, a protective genetic trait, and a relative immunity conferred by the mandatory BCG tuberculosis vaccine.[19]" https://pmc.ncbi.nlm.nih.gov/articles/PMC9559364/ "Japan's basic policy for COVID-19 is to curb the outbreak of infection, maintain the medical system, and focus on dealing with the severely ill [13]. Based on this policy, Japan declared a state of emergency during peaks with non-compulsory self-restraint requirements, allocated hospital beds and at-home care depending on the symptoms of the infected, and preferentially supplied vaccines to the elderly. As of August 19, 2022, 82.1% of the total population nationwide has received the first dose of the vaccine, 81.0% has received the second dose, and 63.9% has received the third dose" What do you mean by no restrictions or regulations for covid in Japan or Norway?
Did you research their RMAT for Lymphopenia? sBLA will be submitted likely within the next 60 days. EAP to be approved likely within next 2 weeks. And unlike other prev cancer vaccines you may have familiarity with, this IL-15 agonist does not attack the bodies own cells. Also sBLA for papillary indication submitted in Q1 which brings 6-10x patient population over current CIS indication approved in April 2024 which sales have been growing 150% quarter over quarter since J-code approval. They’ve solved the shortage of BCG with exclusive rights to rBCG which actually performed better over BCG in trials.
I googled it and I’m not surprised that there is a link to BCG: The investigation, led by outside counsel, found that Buchanan directed Kohl's to work with a vendor, and also enter a consulting agreement involving the same individual, without disclosing his personal relationship with them. The Wall Street Journal reported that this individual was Chandra Holt, who is an advisor at Boston Consulting Group
Anyone have any 4/20 deal suggestions? I always buy something, but I don’t need another dynavap or BCG grinder.
The only way he’d kill deloitte is by tearing down SOX but that would be insane lol. BCG is way more consulting focused
If 🥭 kills Deloitte and BCG it’d be worth it 
Didn't they buy into GOLD when Barrick Goldstrike decided to bring in some Bain/BCG or whatever to cut costs? "These guys mine gold. They've cut costs on labor." Like fucking mind melting stuff there.
There's a reason I'm not overall negative on my investments. It's because I bought the dip every single time for a long time. I am averaging down so to reduce my cost basis. Those who sell, those who wait, are statistically more likely to lose money than those who either simply buy or just hold. [Page 40 of JPMorgan analysis.](https://am.jpmorgan.com/content/dam/jpm-am-aem/global/en/insights/retirement-insights/guide-to-retirement-us.pdf) See also: "**Seven of the 10 best days occurred within two weeks of the 10 worst days.**" >Also why invest in US companies if the people in charge are trying to get of of the dollars status as a reserve currency? Just buy european lmao Name the reserve currency alternative to the dollar - oh wait it does not exist even remotely. Name the alternative to: Visa / Mastercard, Apple / Microsoft, BlackRock / Vanguard, Intel / Nvidia, Google / Bing, McKinsey / BCG. Oh wait...there aren't any viable alternatives to these dominant American businesses. And don't make me laugh you out of the room that Europe of all places could produce an alternative. If an alternative is made - it will be Chinese, not European. See Deepseek, Alibaba, Tencent.
They do it for plausible deniability. If it goes well, the C-Suite can claim credit. If it goes badly, they can say "not our fault, McKinsey/BCG/Bain told us to do it".
Does he understand that Europe has a huge service deficit against the US. AWS, Microsoft, Azure, Salesforce, BCG, McKinsey, Big4 accounting firms, McDonalds, Coca-cola, All high paying HQ jobs are in the US. That's what made it possible for the US to soar ahead of the EU in the last 25 years. Not mining for aluminum or making clothes.
They are literally the only supplier of BCG next to Merck in the US.
Whats everyones AH play today? Thoughts on AH BCG?
BCG - A rather peculiar and risky stock. I’ve dipped in and out 5 times and had a mini heart attack each time. Can somebody explain its behaviour to me please, if you’ve also been following?
Found one of those 100%+ stocks that are still running up. BCG Stock
BCG is pumping, no news or reason , probably a twitter P&D
The (long-term) problem with PLTR is that it is a consulting company with an in-house software shop. Look at their split between how many software engineers vs. business development (forward deployed engineers). Business development is 80% of the game. Would you want to own a consultancy at these P/S metrics? Now, don't get me wrong, they're a very good shop running a tight ship. Consulting is *extremely* lucrative. MBB pays fresh college grads with bumfuk experience top salary to yap at companies and provide business cover. add on that PLTR actually provides a working product, and clients think it's the second coming of their second wife's hot young sister. However, the Foundry platform has a high, high barrier to entry. Use PLTR and you are closed into that ecosystem forever. They are directionally constrained by the fact that very, very few users are building on their platform, and simply using their own consultants (at a high billable rate) to build things that clients pay for in perpetuity. Which, again, is a very good business model. **But it's not a software shop, it's a consultancy.** If McK QuantumBlack or BCG Gamma were spun out and gone public, they could rival PLTR with YoY growth. People need data integration/ingestion services but are ultimately paying for consulting. So: why would you own PLTR at these prices? I'm taking the other side of the bet - they're going to start scaling consultants: employee count goes up, total revenue goes up, but revenue per employee goes down. PLTR will grow into its valuation on a long-term horizon, but medium term, Palantards are in for some pain.
every consultant lead project I’ve seen is a flaming expensive pile of shit that gets dumped in the lap of engineering to fix and maintain when the contract is up. Because they too have no idea about the business. Palantir is going to be no different than Accenture trying to implement a $20 million SAP project. They’ll charge high $$, extract strong margins, and be purely at the mercy of corporate budgeting and under threat of giga chads new favorite golf buddy Palantir isn’t going to be the only one the AI consulting space, they just happen to be more advanced right now. EY, PWC, KPMG, Accenture and McKinsey, BCG, Gemini are all want to be challengers on the implementation side and have decades of existing relationships from other service lines. I’m not saying palantirs a bad buy or a shitty company. But your DD is filled with holes
The risk level of TB is higher outside the US and the benefits of BCG may outweigh the risks in places were it's especially difficult to diagnose and treat
BCG's efficacy is variable and can cause false positives on TB tests making it harder to diagnose. TB risk is also considered low.
>Bacille Calmette-Guérin (BCG) is a vaccine for tuberculosis (TB) disease. This vaccine is not generally used in the United States. From https://www.cdc.gov/tb/vaccines/index.html If the vaccine isn’t being offered, then it’s not a refusal to vaccinate that’s the problem.
Exactly. Please feel free to reply with the values of BCH, BSV, and BCG relative to BTC. They're not good...
I know someone was holding BCG warrants. Are you still in it?
Intel hired BCG so I'm gonna stay away. Other companies that hired BCG eventually went bankrupt.
Bruh, this drug is in Ph1 and their competitor has their Revumenib product APPROVED. Unless they blow it out of the park with their Ph1/2, the market reaction is warranted because they’re not gonna make any money being 6-8 years behind. Especially in oncology, first in class will capture like 100% of market share (at least according to BCG who have actually never brought a drug to market lmao: https://media.nature.com/original/magazine-assets/d41573-023-00048-2/d41573-023-00048-2.pdf)
Idk it's been 2 days I think it's going to cool off it's maybe worth more, but I don't think tomorrow is the time to play at it plus dividend is counted on the 21st on BCG.
BCG would like a word (no cap mania)
BCG is pumping, not sure if some Stocktwits fake “low float “pump & dump, but I’ll take it if I can offload some of these warrants I’ve been holding since the KWAC days!
Many businesses are finding AI to help with internal optimization vs customer facing products. If a business can be 10% more efficient, there is a huge cost savings to the company that shows in the bottom line. https://www.ciodive.com/news/generative-ai-cost-savings-ROI-investments/704513/#:\~:text=More%20than%20half%20of%20C,of%2010%25%2C%20BCG%20found.
When I said I assume it's SOP I said that because every person I know who works at a bank and/or works for McKinsey, BCG, or Bain has the same restrictions, obviously in your case that didn't happen but that's a major liability your employer(s) is leaving open. Chase knew what trades my wife made in her brokerage account with BofA/ML under her maiden name.
Was it Mck or BCG this time ?
I would also like to HIGHLIGHT that the current treat option BCG has a 40% failure rate.
I've worked with BCG twice. I don't get them. We learned nothing in both cases. Just a room full of consultants going "yeah you're going everything right. We have no suggestions". Sweet... Heres your massive check that you definitely earned.
Intel has hired BCG which is what companies usually do when determined file for bankruptcy.
I just strongly disagree. There’s no pre-IPO partners left 23 years later who would be driving this “AA culture.” But maybe you work for ACN, Deloitte, McKinsey, BCG or Bain and have the inside insight?
As long as BCG is not involved. Everything they touch takes out loans and buys back shares, then files Ch7.
BCG involved with Intel means this company is going bankrupt in a few years.
...and you're 100% going bankrupt if BCG is hired on as consultants where you work.
Best part is they probably payed KPMG or BCG millions for that advice. “How do we cut costs?” “Ehh… have you tried yoinking the Folgers out of the break room? That’ll save some money. BTW, there’s a 4,000 hour invoice in the mail.”
BCG=shit I can't link you to the tons of Reddit posts on this because I would get banned for brigading
Yes, I read about the India move some months ago. It seems like it's a very wise move on the part of Soon, since Anktiva is so dependent on a regular supply of BCG. He sounds like an incredible visionary; let's hope that it translates into full approval and usage of Anktiva, and a nice appreciation in the stock price.
u/Bossie81 I have a few questions: 1) How is it that IBRX's accumulated deficit of $3.2 billion is more than half of Soon-Shiong's net worth, if he didn't deliberately saddle it with debt (I'm not saying he did; I'm just asking)? 2) Are there any official dates or timelines by which UK approval is expected? 3) If IBRX only has enough cash and cash equivalents to fund operations through at least 12 months, doesn't that mean a share dilution is very likely in the near future? Wouldn't IBRX be "cutting things a bit close" if they don't do it within the next 3 months? 4) The stock price is lower today than it was when the FDA approval was given. What does this mean for sales? Does it - for example - mean that other drugs are being preferred, over Anktiva? Does it mean that Anktiva's efficacy has been exaggerated, since it's not effective on its own but has to be taken alongside BCG? 5) Which other drugs are competing with Anktiva in the treatment of NIMBC, and how do their sales compare with those of Anktiva?
They must have brought on BCG consultants
> their books are actually solid If true then they wouldn’t currently be looking to offload assets to find quick cash lol > the short term pain will end They’ve been losing market share on all fronts for nearly a decade and revenue is nearly $20B lower than what their 5 year guidance projected in 2020. This isn’t short term pain. > Their margins are identical to AMDs Intel’s margins have been collapsing over the past decade from 65% down to 41% in the TTM. AMD’s have been climbing from 35% a decade ago to 46% today. Again, they’re not the same > Their market share is double AMD’s And falling > Their net income is in line with AMD’s on an adjusted basis Adjusted earnings are kind of a joke. If you’re going to compare any profitability metrics other than GAAP accounting, it should be FCF. AMD took in $1.5B cash in the TTM while Intel burned $12B. They’re desperate for money. > Find me another company with 53bn in revenue and a P/B <1. GM, the company that mismanaged their way into bankruptcy and is trading at the same stock price they were 30 years ago. > Goldman Sachs, JPM, and BCG have been in contact with the board Intel’s credit recently got downgraded to BBB+ which spooked lenders. It’s rarely a good thing when the people you owe money to are contacting your board. To be clear, I’ve been bearish on Intel for years, but have been buying in at sub $20. I think there’s a path here for them to succeed, but by no means is this “the best value investment of the decade.” They’re horribly managed and most of the top execs need to be booted out before we see any real change.
People are bullish on Intel because their books are actually solid and the short term pain will end. Their margins are identical to AMD's, their market share is double AMD's, their net income is in line with AMD's on an adjusted basis. Yet Intel is trading at 1.7 P/S and AMD at 9.7. You want more? Emergency shareholder this month. You want more? Price to book ratio of 0.78. Find me another company with 53bn in revenue and a P/B <1. You want more? Goldman Sachs, JPM and BCG have been in direct contact with the board. At what point do people stop parroting WSB bullshit and realize this is probably one of the best value investments of the decade. Also fuck that dividend, no volatility in dividend stocks because only boomers buy them, glad all those fucks got shook up, if covid can't kill them at least they lost money on INTC.
My company was a client of BCG and their incompetence is staggering. A lot of their consultants don’t have real world experience to rely on.
Oh yea, worked with them, McK, BCG etc… is what i call spending money on executive to teach you how to throw money down the drain.
All my homies hate BCG.
There have been examples earlier this year of SPACs that were delisted to OTC, then completed the business combination, then uplisted back to NASDAQ. [AIB Acquisition Corporation moved to OTC Market](https://www.sec.gov/Archives/edgar/data/1882963/000121390024042306/ea0205727-8k_aibacq.htm) \- AIB -> OTC Pink: AIBAF AIBBR -> OTC Pink: AACRF on May 13, 2024; PSI and AIB Acquisition completed business combination - OTC Pink: AIBAF -> NASDAQ:PSIG AACRF/10 -> PSIG on July 19, 2024 [Kingswood Acquisition Corp. To Transfer Listing to OTC Markets Group Inc.](https://www.prnewswire.com/news-releases/kingswood-acquisition-corp-to-transfer-listing-to-otc-markets-group-inc-301586313.html) \- KWAC KWAC.WS July 2022; [Binah Capital Group, Inc. Announces Listing on Nasdaq Stock Market LLC](https://www.prnewswire.com/news-releases/binah-capital-group-inc-announces-listing-on-nasdaq-stock-market-llc-302098940.html) \- OTCBB: KWAC -> NASDAQ: BCG OTC Pink: KWACW -> NASDAQ: BCGWW on March 27, 2024 So just because a SPAC gets downlisted to OTC does not necessarily mean it will be unable to complete the business combination and relist on NASDAQ or the NYSE.
Work at BCG/Bain/Mck for 3-5 years. Exit to any industry you want. Simple as that. Once you get the first good name on your resume for a few years the corporate world is yours and you can find your way into any job you would like in most fields
Not BCG, but I was working for a big industrial project a few years ago that hired an investment bank to put together an economic plan of some kind as we were building our investment materials. I had previously been asked to make a slide deck mostly for internal use, and partially to help brief the banker guys. A few weeks later, they give us this fancy slide deck and plan to share with investors, and what do you know? About half the slides were ripped DIRECTLY from my deck with some changes to the design and colors. I don’t even want to know how much we paid them for that but it was a hell of a lot more than I was making, that’s for sure.
You think a BCG engagement costs $500k?
My company was started by BCG digital ventures, the arm of BCG that start new corporate startups for old corporate companies. When BCG became too expensive, they hired regular full time employees like me to take over the project. the things BCG delivered was absolute garbage, a lot of innovation theater. Put us more than a year back.
Last time my company hired BCG, they found a lot of solutions to something that wasnt a problem for anyone. All that for 500k. And a fancy end-report Powerpoint presentation.
Smells like BCG at it again.
Wonder if BCG is consulting them on this path. Seems like this stock might be getting cellarboxed.
It was good and I missed it lol, but who knows if BCG ever pumps to >10, and warrants hit a dollar, I’m buying a new car! Jk , more shit warrant gambling
That's why they did the split..so..thier cronies can short it..BCG ?
Consultant here - let me explain. First, you have to understand what kind of consulting you want to do - strategy, operational, technology, etc. Next, you have to decide if you want to work for one of the big players in the space - McKinsey, BCG, Booz, or the Big 4 (Deloitte, PWC, EY, KPMG) or Accenture. Each has their own areas of specialty and needs at any given moment. After that, unless you're getting hired right out of college, you have to have some kind of relevant professional experience in an area of need for one of those firms. Alternatively, you could work for a boutique firm that does one very specific thing, but does it well, and see if they're interested. As OP noted, it's a competitive field - people generally don't stagnate in their careers, even after they make Partner (the consulting equivalent of an executive). If you're not moving up, you're likely moving out. TBH, it's mostly luck. Just being in the right place at the right time with the right skills, and being ready and willing to put in the work.
That's interesting. I know nothing about NVCR, but IBRX has been on my watchlist for a while. I've been following the saga of whether Anktiva sales will increase significantly since the FDA has approved it in combination with BCG[ for treating BCG-](https://ir.immunitybio.com/news-releases/news-release-details/immunitybio-announces-fda-approval-anktivar-first-class-il-15)unresponsive NIMBC. I've been held back by a few headwinds - the current shortage of BGC - hopefully to be addressed by SII - (the Serum Institute of India), the fact that IBRX could run out of money in a couple of quarters and the fairly significant short interest (I try not to pay too much attention to short interest, but sometimes you can't help but take a look). How confident are you that IBRX will come out on top of these, before they run out of cash? Do you think they'll have to dilute their shares?
You're answering like you're in an interview for BCG.
fuck MCdonalds , they got that bitch CEO from BCG